Bluejay Diagnostics, Inc. · NASDAQ:BJDX
Armistice Capital, LLC reported a 9.99% stake in Bluejay Diagnostics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 9.99% stake in Bluejay Diagnostics, Inc., 142,728 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 142,728
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 142,728 |
| Steven Boyd | 9.99% | 142,728 |
Source
Related
- Bluejay Diagnostics, Inc.
- Armistice Capital, LLC
- Bluejay Diagnostics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Form 4 · Dey Indranil · Aug 18, 2026
- Schedule 13G · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Hrt Financial LP · Jul 13, 2026
- Schedule 13G · Mitchell P. Kopin · Jun 5, 2026
- Schedule 13D/A · Braeden Lichti · Jun 2, 2026